|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 403/14 | |
| C07D 417/14 | |||
| C07D 471/04 | |||
| A61K 31/4725 | |||
| A61P 27/00 |
| (11) | Number of the document | 2999697 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14727034.2 |
| Date of filing the European patent application | 2014-05-23 | |
| (97) | Date of publication of the European application | 2016-03-30 |
| (45) | Date of publication and mention of the grant of the patent | 2017-04-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2014/051592 |
| Date | 2014-05-23 |
| (87) | Number | WO 2014/188211 |
| Date | 2014-11-27 |
| (30) | Number | Date | Country code |
| 201361826596 P | 2013-05-23 | US | |
| 201361865756 P | 2013-08-14 | US |
| (72) |
DAVIE, Rebecca Louise, GB
EDWARDS, Hannah Joy, GB
EVANS, David Michael, GB
HODGSON, Simon Teanby, GB
MILLER, Iain, GB
NOVAK, Andrew Richard, GB
SMITH, Alun John, GB
STOCKS, Michael John, GB
|
| (73) |
Kalvista Pharmaceuticals Limited,
Building 227 Tetricus Science park, Salisbury, Wiltshire SP4 0JQ,
GB
|
| (54) | HETEROCYCLIC DERIVATES |
| HETEROCYCLIC DERIVATES |